Anavex Life Sciences Corp. (AVXL)
NASDAQ: AVXL · Real-Time Price · USD
4.790
+0.140 (3.01%)
At close: Mar 9, 2026, 4:00 PM EDT
4.800
+0.010 (0.21%)
After-hours: Mar 9, 2026, 7:48 PM EDT
Anavex Life Sciences Market Cap
Anavex Life Sciences has a market cap or net worth of $443.90 million as of March 9, 2026. Its market cap has decreased by -37.51% in one year.
Market Cap
443.90M
Enterprise Value
312.15M
1-Year Change
-37.51%
Ranking
Category
Stock Price
$4.79
Market Cap Chart
Since October 28, 2015, Anavex Life Sciences's market cap has increased from $284.60M to $443.90M, an increase of 55.97%. That is a compound annual growth rate of 4.38%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 9, 2026 | 443.90M | 39.55% |
| Dec 31, 2025 | 318.10M | -65.08% |
| Dec 31, 2024 | 910.90M | 19.20% |
| Dec 29, 2023 | 764.20M | 5.86% |
| Dec 30, 2022 | 721.90M | -45.24% |
| Dec 31, 2021 | 1.32B | 264.55% |
| Dec 31, 2020 | 361.60M | 148.69% |
| Dec 31, 2019 | 145.40M | 100.00% |
| Dec 31, 2018 | 72.70M | -48.95% |
| Dec 29, 2017 | 142.40M | -9.24% |
| Dec 30, 2016 | 156.90M | -18.58% |
| Dec 31, 2015 | 192.70M | -32.29% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Entrada Therapeutics | 452.88M |
| Lineage Cell Therapeutics | 448.31M |
| Assembly Biosciences | 447.15M |
| REGENXBIO | 446.45M |
| vTv Therapeutics | 439.40M |
| Tenax Therapeutics | 433.70M |
| 4D Molecular Therapeutics | 432.55M |
| Sutro Biopharma | 414.45M |